Zymeworks Inc. ZYME 深 滬
已收盤 09-18 16:00:00 美东时间
12.52
+0.220
+1.79%
華盛通- 最 高12.78
- 今 開12.30
- 成交量 63.18万股
- 最 低 12.245
- 昨 收 12.30
- 總市值 8.49亿
- 52周最高 13.14
- 市盈率 靜 --
- 換手率 0.93%
- 52周最低 6.015
- 委 比 -48.55%
- 總股本 6782.67万
- 歷史最高 59.03
- 量 比 0.75
- 振 幅 4.35%
- 歷史最低 4.11
- 每 手 1
- 風險率 1.65%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Zymeworks’ Hold Rating Amidst Promising Data and Competitive HER2+ GEA Treatment Landscape
Analyst Robert Burns from H.C. Wainwright reiterated a Hold rating on Zymeworks...
09-18 18:25
Adcentrx Therapeutics 宣布成立科学顾问委员会
上海和加利福尼亚州圣迭戈，2024年 9月11日， Adcentrx Therapeutics(以下简称“Adcentrx”)，一家专注于开发针对癌症和其他...
09-11 13:53
默沙东行使SKB571权利，双抗ADC来到风口之上
关注并星标CPHI制药在线 近日，科伦博泰公布了与默沙东合作项目的最新进展，其中重点披露了默沙东将就双抗ADC药物SKB571行使独家选择权，并向科伦博泰支付...
08-23 17:47
Zymeworks Engages Investors, Awaits Drug Approval
Zymeworks (ZYME) has released an update. Zymeworks Inc., a biotech firm focused...
08-22 19:08
Stifel Maintains Buy on Zymeworks, Raises Price Target to $21
Stifel analyst Stephen Willey maintains Zymeworks (NASDAQ:ZYME) with a Buy and raises the price target from $20 to $21.
08-03 01:58
Zymeworks终止HER2双抗ADC开发
8月1日，Zymeworks在2024Q2财报中透露，在对公司新兴的全资管线进行战略评估后，决定正式终止HER2双抗ADC ZW49（zanidatama...
08-02 16:28
Zymeworks Announces Share Repurchase Program Of Up To $60M Of Common Stock
Zymeworks Inc. (NASDAQ:ZYME) (the "Company"), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat
08-02 05:18
Zymeworks Announces Stock Buyback, Projects Long-Term Funding
An update from Zymeworks (ZYME) is now available. Zymeworks Inc. has announced ...
08-02 04:49
Zymeworks Q2 2024 GAAP EPS $(0.49) Misses $0.07 Estimate, Sales $19.243M Miss $48.860M Estimate
Zymeworks (NYSE:ZYME) reported quarterly losses of $(0.49) per share which missed the analyst consensus estimate of $0.07 by 800 percent. This is a 35.53 percent increase over losses of $(0.76) per share from the same
08-02 04:40
快讯 | Zymeworks公司将为未来回购储备3,000万美元。
Zymeworks Inc - to Reserve $30M for Future Repurchases
08-02 04:12
